Evidence map›Paper›PMID 35403125›Full record

ArticleCancer diagnosis & prognosis

Real-time IR700 Fluorescence Imaging During Near-infrared Photoimmunotherapy Using a Clinically-approved Camera for Indocyanine Green.

Shuhei Okuyama, Daiki Fujimura, Fuyuki Inagaki, Ryuhei Okada, Yasuhiro Maruoka, Hiroaki Wakiyama, Takuya Kato, Aki Furusawa, Peter L Choyke, Hisataka Kobayashi

Open access · greenAbstract read
In one paragraph

Article in Cancer diagnosis & prognosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Shuhei OkuyamaShimadzu Corporation, Kyoto, Japan.
Daiki FujimuraShimadzu Corporation, Kyoto, Japan.
Fuyuki InagakiMolecular Imaging Branch, Center for Cancer Research, National CancerInstitute, National Institutes of Health, Bethesda, MD, U.S.A.
Ryuhei OkadaMolecular Imaging Branch, Center for Cancer Research, National CancerInstitute, National Institutes of Health, Bethesda, MD, U.S.A.
Yasuhiro MaruokaMolecular Imaging Branch, Center for Cancer Research, National CancerInstitute, National Institutes of Health, Bethesda, MD, U.S.A.
Hiroaki WakiyamaMolecular Imaging Branch, Center for Cancer Research, National CancerInstitute, National Institutes of Health, Bethesda, MD, U.S.A.
Takuya KatoMolecular Imaging Branch, Center for Cancer Research, National CancerInstitute, National Institutes of Health, Bethesda, MD, U.S.A.
Aki FurusawaMolecular Imaging Branch, Center for Cancer Research, National CancerInstitute, National Institutes of Health, Bethesda, MD, U.S.A.
Peter L ChoykeMolecular Imaging Branch, Center for Cancer Research, National CancerInstitute, National Institutes of Health, Bethesda, MD, U.S.A.
Hisataka KobayashiMolecular Imaging Branch, Center for Cancer Research, National CancerInstitute, National Institutes of Health, Bethesda, MD, U.S.A.
Shimadzu (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Aim: Near-infrared photoimmuno-therapy (NIR-PIT) is a newly approved cancer phototherapy. We aim to confirm whether a clinically approved camera for indocyanine green (ICG) could monitor IR700 fluorescence in real time during exposure to therapeutic NIR light. Materials and Methods: An NIR camera, LIGHTVISION, designed to image ICG fluorescence, was used. A431-GFP/luc tumor-bearing mice were exposed to therapeutic NIR light and real-time fluorescence imaging (RT-FI) was obtained and measured with LIGHTVISION. Bioluminescence imaging (BLI) was performed to confirm cell death. Results: RT-FI during NIR-PIT revealed an initial rapid loss of fluorescence, followed by a plateau which occurred at a light dose of approximately 30 J/cm Conclusion: The efficacy of NIR-PIT could be monitored non-invasively and in real-time using weak fluorescence at wavelengths much longer than the peak fluorescence of IR700. This technique can achieve precise light dosimetry that allows us to decide on the optimal exposure.

Indexed as

ICG cameraIR700Near infraredphotoimmunotherapyreal-time fluorescence imaging

Identifiers

PMID35403125
PMCPMC8962761
OpenAlexW3208041228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.